To evaluate DNA methylation and gene expression differences between “EGFR Wild Type/Low PD-L1 expression” NSCLC samples and non-tumor samples, we constructed 249-DMEGs and 297-DMSs-based random forest classifiers, followed by PCA and ROC analyses. The gene discussed is EGFR; the disease is neoplasm.